News: Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

98.28EUR
6:03am EDT
Change (% chg)

€-0.02 (-0.02%)
Prev Close
€98.30
Open
€98.15
Day's High
€98.81
Day's Low
€97.80
Volume
7,296
Avg. Vol
32,851
52-wk High
€109.65
52-wk Low
€76.98

Search Stocks
Select another date:

Mon, Aug 31 2015

BRIEF-Biomerieux H1 operating income rises to 103 million euros

* H1 net income of consolidated companies 59 million euros ($66.42 million) versus 51 million euros a year ago

BRIEF-BioMerieux receives FDA 510(k) clearance for Vidas 3

* Vidas 3 is CE marked and registered at Chinese Food and Drug Administration (CFDA) which makes it available to clinical labs on a global scale Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Biomerieux H1 sales rises to 933 million euros

* Consolidated sales amount to 933 million euros ($1.02 billion) in first half of 2015, up from 781 million euros in year-earlier period

BRIEF-Biomerieux Q1 revenue rises to 447.9 million euros

* Q1 revenue 447.9 million euros ($479.79 million) versus 370.8 million euros a year ago

BRIEF-Biomerieux unit Biofire submits de novo classification request to FDA

* Company unit Biofire submits de novo application to FDA for FilmArray meningitis/encephalitis panel

Select another date:
Search Stocks